tiprankstipranks
Trending News
More News >
ILEX Medical Ltd. (IL:ILX)
:ILX
Israel Market
Advertisement

Ilex Medical (ILX) Ratios

Compare
0 Followers

Ilex Medical Ratios

IL:ILX's free cash flow for Q2 2025 was 0.23. For the 2025 fiscal year, IL:ILX's free cash flow was decreased by and operating cash flow was 0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.09 2.46 2.81 2.63 2.00
Quick Ratio
2.39 1.89 2.17 2.15 1.51
Cash Ratio
0.85 0.53 0.89 1.08 0.57
Solvency Ratio
0.33 0.25 0.53 0.83 0.48
Operating Cash Flow Ratio
0.27 0.29 0.31 1.13 0.65
Short-Term Operating Cash Flow Coverage
566.47 194.28 124.76 238.90 11.78
Net Current Asset Value
388.47M 293.40M 348.75M 332.23M 223.28M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.05 0.06 0.07 0.09
Debt-to-Equity Ratio
0.07 0.08 0.08 0.10 0.15
Debt-to-Capital Ratio
0.07 0.07 0.08 0.09 0.13
Long-Term Debt-to-Capital Ratio
0.00 <0.01 <0.01 <0.01 <0.01
Financial Leverage Ratio
1.43 1.63 1.47 1.52 1.76
Debt Service Coverage Ratio
71.52 34.25 70.99 75.92 8.87
Interest Coverage Ratio
47.71 30.89 98.39 124.23 61.36
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 0.01
Interest Debt Per Share
4.29 4.55 4.71 5.39 6.48
Net Debt to EBITDA
-1.16 -0.81 -0.79 -0.68 -0.50
Profitability Margins
Gross Profit Margin
23.20%24.91%32.67%35.76%28.64%
EBIT Margin
7.79%8.15%15.86%24.26%16.50%
EBITDA Margin
13.17%13.28%21.59%27.96%19.70%
Operating Profit Margin
6.89%8.81%18.12%23.56%15.46%
Pretax Profit Margin
7.73%7.46%15.67%24.07%16.25%
Net Profit Margin
4.96%5.47%11.70%18.61%12.74%
Continuous Operations Profit Margin
5.69%5.47%11.70%18.61%13.31%
Net Income Per EBT
64.20%73.32%74.68%77.34%78.43%
EBT Per EBIT
112.20%84.61%86.48%102.16%105.14%
Return on Assets (ROA)
4.81%5.01%11.36%22.57%15.48%
Return on Equity (ROE)
7.03%8.16%16.66%34.31%27.20%
Return on Capital Employed (ROCE)
8.69%11.12%23.48%39.37%29.25%
Return on Invested Capital (ROIC)
6.29%8.03%17.21%29.83%22.86%
Return on Tangible Assets
4.92%5.15%11.78%23.26%16.14%
Earnings Yield
6.04%7.73%9.03%10.77%9.19%
Efficiency Ratios
Receivables Turnover
3.51 3.25 3.51 4.82 3.95
Payables Turnover
7.34 4.06 4.13 5.48 4.15
Inventory Turnover
4.61 4.38 4.03 5.86 4.94
Fixed Asset Turnover
6.18 5.79 6.01 7.01 6.11
Asset Turnover
0.97 0.92 0.97 1.21 1.21
Working Capital Turnover Ratio
2.08 2.28 2.18 3.16 3.96
Cash Conversion Cycle
133.40 105.75 106.02 71.36 78.24
Days of Sales Outstanding
103.88 112.24 103.85 75.68 92.35
Days of Inventory Outstanding
79.23 83.38 90.59 62.29 73.86
Days of Payables Outstanding
49.71 89.87 88.43 66.61 87.97
Operating Cycle
183.11 195.62 194.45 137.97 166.21
Cash Flow Ratios
Operating Cash Flow Per Share
5.26 7.19 6.18 23.99 17.10
Free Cash Flow Per Share
2.66 2.53 3.67 20.21 12.75
CapEx Per Share
2.60 4.66 2.51 3.78 4.35
Free Cash Flow to Operating Cash Flow
0.51 0.35 0.59 0.84 0.75
Dividend Paid and CapEx Coverage Ratio
1.38 1.09 0.79 2.64 3.93
Capital Expenditure Coverage Ratio
2.02 1.54 2.46 6.35 3.93
Operating Cash Flow Coverage Ratio
1.26 1.67 1.35 4.61 2.73
Operating Cash Flow to Sales Ratio
0.06 0.09 0.08 0.26 0.19
Free Cash Flow Yield
3.95%4.30%3.66%12.43%10.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.56 12.93 11.08 9.29 10.88
Price-to-Sales (P/S) Ratio
0.82 0.71 1.30 1.73 1.39
Price-to-Book (P/B) Ratio
1.14 1.06 1.85 3.19 2.96
Price-to-Free Cash Flow (P/FCF) Ratio
25.29 23.28 27.34 8.04 9.65
Price-to-Operating Cash Flow Ratio
12.82 8.18 16.22 6.78 7.20
Price-to-Earnings Growth (PEG) Ratio
0.50 -0.26 -0.23 0.17 0.12
Price-to-Fair Value
1.14 1.06 1.85 3.19 2.96
Enterprise Value Multiple
5.07 4.51 5.21 5.51 6.54
Enterprise Value
613.70M 557.85M 981.88M 1.63B 1.22B
EV to EBITDA
5.07 4.51 5.21 5.51 6.54
EV to Sales
0.67 0.60 1.13 1.54 1.29
EV to Free Cash Flow
20.59 19.74 23.73 7.16 8.96
EV to Operating Cash Flow
10.42 6.94 14.08 6.04 6.68
Tangible Book Value Per Share
57.09 53.20 51.51 48.72 38.59
Shareholders’ Equity Per Share
58.92 55.72 54.36 51.02 41.57
Tax and Other Ratios
Effective Tax Rate
0.26 0.27 0.25 0.23 0.18
Revenue Per Share
82.01 83.19 77.36 94.05 88.70
Net Income Per Share
4.07 4.55 9.05 17.51 11.30
Tax Burden
0.64 0.73 0.75 0.77 0.78
Interest Burden
0.99 0.91 0.99 0.99 0.98
Research & Development to Revenue
<0.01 0.01 0.01 <0.01 <0.01
SG&A to Revenue
<0.01 <0.01 0.01 <0.01 <0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.92 1.16 0.51 1.06 1.19
Currency in ILS
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis